Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
205.2 USD | -0.81% | -10.70% | -11.29% |
Chart calendar Madrigal Pharmaceuticals, Inc.
Upcoming events on Madrigal Pharmaceuticals, Inc.
Past events on Madrigal Pharmaceuticals, Inc.
2024-05-07 08:00 am | Q1 2024 Earnings Call |
2024-05-07 07:00 am | Q1 2024 Earnings Release |
2024-03-14 05:15 pm | Rezdiffra™ (resmetirom) Accelerated Approval Call |
2024-02-28 07:00 am | Q4 2023 Earnings Release |
2024-01-10 07:30 pm | JPMorgan Healthcare Conference |
2024-01-03 | NASH TAG Conference - Abstract No:27 |
2024-01-03 | NASH TAG Conference - Abstract No:26 |
2024-01-03 | NASH TAG Conference - Abstract No:25 |
2024-01-03 | NASH TAG Conference - Abstract No:21 |
2024-01-03 | NASH TAG Conference - Abstract No:41 |
2023-11-30 01:00 pm | Piper Sandler Healthcare Conference |
2023-11-29 03:00 pm | Evercore ISI HealthCONx Conference |
2023-11-08 05:00 pm | UBS BioPharma Conference |
2023-11-06 08:00 am | Q3 2023 Earnings Release |
2023-08-08 08:00 am | Q2 2023 Earnings Release |
2023-06-24 12:30 pm | European Association for the Study of the Liver Congress |
2023-06-15 09:00 am | Annual General Meeting |
2023-06-13 12:20 pm | Goldman Sachs Global Healthcare Conference |
2023-06-07 02:30 pm | Jefferies Global Healthcare Conference |
2023-05-16 10:30 am | JMP Securities Life Sciences Conference |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 76,3 |
EBITDA Million USD | Released Forecast Spread | -94,9 -93,5 -1.44% | -206 -209 1.32% | -242 -244 0.7% | -293 -291 -0.77% | -380 -379 -0.29% | -549 |
EBIT Million USD | Released Forecast Spread | -95,0 -93,4 -1.66% | -207 -209 1.12% | -242 -244 0.66% | -294 -286 -2.59% | -380 -372 -2.42% | -591 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -83,9 -80,3 -4.57% | -202 -203 0.44% | -242 -242 0.26% | -295 -286 -3.35% | -374 -364 -2.75% | -582 |
Net income Million USD | Released Forecast Spread | -83,9 -80,3 -4.6% | -202 -203 0.44% | -242 -243 0.44% | -295 -287 -2.85% | -374 -365 -2.29% | -570 |
EPS USD | Released Forecast Spread | -5,45 -5,30 -2.74% | -13,1 -13,2 1.11% | -14,6 -14,7 0.21% | -17,2 -16,8 -2.69% | -20,0 -19,4 -2.78% | -27,7 |
Announcement Date | 26/02/20 | 25/02/21 | 24/02/22 | 23/02/23 | 28/02/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 4,13 | 21,2 | 50,1 | 54,8 | 72,9 |
EBITDA Million USD | Released Forecast Spread | -78,2 -88,5 11.6% | -152 -129 -17.96% | -138 | -135 | -124 | |||||||||
EBIT Million USD | Released Forecast Spread | -57,6 -60,6 4.98% | -70,3 -63,8 -10.22% | -80,4 -73,0 -10.17% | -85,3 -77,9 -9.49% | -78,3 -86,7 9.6% | -86,5 -84,7 -2.03% | -98,5 -92,9 -6.02% | -117 -108 -8.27% | -152 -130 -16.89% | -161 | -152 | -132 | -139 | -127 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -57,5 -58,6 1.89% | -70,7 -65,3 -8.24% | -81,2 -71,3 -13.81% | -85,9 -76,6 -12.18% | -76,9 -87,8 12.46% | -85,8 -83,5 -2.71% | -98,7 -89,9 -9.86% | -112 -103 -8.51% | -148 -125 -18.22% | -161 | -150 | -126 | -122 | -114 |
Net income Million USD | Released Forecast Spread | -57,5 -60,0 4.06% | -70,7 -64,1 -10.29% | -81,2 -72,6 -11.89% | -85,9 -77,9 -10.23% | -76,9 -86,7 11.32% | -85,8 -82,6 -3.94% | -98,7 -90,1 -9.64% | -112 -105 -7.1% | -148 -123 -19.9% | -155 | -145 | -125 | -122 | -114 |
EPS USD | Released Forecast Spread | -3,36 -3,56 5.72% | -4,14 -3,68 -12.54% | -4,75 -4,14 -14.77% | -4,98 -4,50 -10.57% | -4,23 -4,99 15.15% | -4,69 -4,55 -3.12% | -5,34 -4,88 -9.4% | -5,68 -5,26 -7.88% | -7,38 -6,20 -19.09% | -7,48 | -6,94 | -5,98 | -6,38 | -5,84 |
Announcement Date | 09/05/22 | 04/08/22 | 03/11/22 | 23/02/23 | 09/05/23 | 08/08/23 | 06/11/23 | 28/02/24 | 07/05/24 | - | - | - | - | - |
Past sector events for Madrigal Pharmaceuticals, Inc.
2024-05-09 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release (Projected) |
2024-05-09 04:15 pm | ANAPTYSBIO, INC.: Q1 2024 Earnings Release |
2024-05-09 04:10 pm | ASTRIA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-09 04:09 pm | XENCOR, INC.: Q1 2024 Earnings Release |
2024-05-09 04:02 pm | SPYRE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-09 04:01 pm | MACROGENICS, INC.: Q1 2024 Earnings Release |
2024-05-09 04:01 pm | ARROWHEAD PHARMACEUTICALS, INC.: Q2 2024 Earnings Release |
2024-05-09 04:00 pm | ALX ONCOLOGY HOLDINGS INC.: Q1 2024 Earnings Release |
2024-05-09 08:00 am | FRAZIER LIFESCIENCES ACQUISITION CORPORATION: Q1 2024 Earnings Release |
2024-05-09 07:30 am | WAVE LIFE SCIENCES LTD.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- MDGL Stock
- Calendar Madrigal Pharmaceuticals, Inc.